What happens to drug use and expenditure when cost sharing is completely removed? Evidence from a Canadian provincial public drug plan-Reference-Cited by-同舟云学术

What happens to drug use and expenditure when cost sharing is completely removed? Evidence from a Canadian provincial public drug plan

Published:2020-09 Issue:9 Volume:124 Page:977-983
ISSN:0168-8510
Container-title:Health Policy
language:en
Short-container-title:Health Policy

Author:

Laba Tracey-Lea,Cheng Lucy,Worthington Heather C.^ORCID,McGrail Kimberlyn M.^ORCID,Chan Fiona K.I.,Mamdani Muhammad,Law Michael R.

Funder

National Health and Medical Research Council

Canada Research Chair

Michael Smith Foundation for Health Research Scholar Award

Institute for Health System Transformation and Sustainability

Canadian Institutes for Health Research Foundation Scheme Grant

Publisher

Elsevier BV

Subject

Health Policy

Reference26 articles.

1. A systematic review of cost-sharing strategies used within publicly-funded drug plans in member countries of the organisation for economic co-operation and development;Barnieh;PLoS One,2014

2. Blunt policy instruments deliver blunt policy outcomes: why cost sharing is not effective at controlling utilization and improving health system efficiency;Essue;Medical Care,2016

3. Pharmaceutical policies: effects of cap and co-payment on rational use of medicines;Luiza;The Cochrane Database of Systematic Reviews,2015

4. Association between drug insurance cost sharing strategies and outcomes in patients with chronic diseases: a systematic review;Mann;PLoS One,2014

5. Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries;Morgan;BMJ Open,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Associations of Prescription Drug Insurance and Cost-Sharing With Drug Use, Health Services Use, and Health: A Systematic Review of Canadian Studies;Value in Health;2023-07

2. The impact of a reimbursement rate reduction on the utilization of antiulcer, antidepressants and antidiabetics in Portugal: A time series analysis;International Journal of Healthcare Management;2023-03-29

3. Association of Participation in a Value-Based Insurance Design Program With Health Care Spending and Utilization;JAMA Network Open;2023-03-13

4. The impact of introducing multidisciplinary care assessments on access to rheumatology care in British Columbia: an interrupted time series analysis;BMC Health Services Research;2022-03-11

5. Effects of the Full Coverage Policy of Essential Medicines on Inequality in Medication Adherence: A Longitudinal Study in Taizhou, China;Frontiers in Pharmacology;2022-02-03